True Diagnostics

True Diagnostics

Biotechnology, 2782 Loker Ave W, Carlsbad, California, 92010, United States, 1-10 Employees

truediag.com

  • twitter
  • LinkedIn

phone no Phone Number: 88********

Who is TRUE DIAGNOSTICS

True Diagnostics (True) designs and develops innovative POC diagnostic tests and devices based on its proprietary TrueDXTM Platform, which utilizes reliable and low-cost lab methods and i...

Read More

map
  • 2782 Loker Ave W, Carlsbad, California, 92010, United States Headquarters: 2782 Loker Ave W, Carlsbad, California, 92010, United States
  • 2011 Date Founded: 2011
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Jerry Lee CEO:   Jerry Lee

industries-icon Industry: Biotechnology

SIC SIC Code: 2835 | NAICS Code: 325413 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TRUE DIAGNOSTICS

True Diagnostics Org Chart and Mapping

Employees

Shastine Aguilan

Regulatory Affairs Specialist

Jesse Perez

Research and Development Chemist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding True Diagnostics

Answer: True Diagnostics's headquarters are located at 2782 Loker Ave W, Carlsbad, California, 92010, United States

Answer: True Diagnostics's phone number is 88********

Answer: True Diagnostics's official website is https://truediag.com

Answer: True Diagnostics's revenue is $1 Million to $5 Million

Answer: True Diagnostics's SIC: 2835

Answer: True Diagnostics's NAICS: 325413

Answer: True Diagnostics has 1-10 employees

Answer: True Diagnostics is in Biotechnology

Answer: True Diagnostics contact info: Phone number: 88******** Website: https://truediag.com

Answer: True Diagnostics (True) designs and develops innovative POC diagnostic tests and devices based on its proprietary TrueDXTM Platform, which utilizes reliable and low-cost lab methods and its own proprietary or partnered biomarkers to offer rapid diagnoses to facilitate treatment decisions in point-of-care, point-of-incidence and remote-of-care settings. The TrueDX Platforms portability and affordability allow it to be easily adopted into emerging markets to provide accurate diagnosis within minutes. For the $21 billion point-of-care market, the power of the TrueDX Platform lies in its simplicity and flexibility. Tests have an 18-month or longer shelf life with no refrigeration required. The platforms flexible design additionally permits it to quickly commercialize a myriad of biomarkers discovered for cancer, autism, Alzheimers, diabetes, drugs of abuse, infectious diseases, cardiac health, traumatic brain injury, viral and bacterial infections and more.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access